PureTech Health (PRTC) Other Non-Current Liabilities (2020 - 2025)
PureTech Health (PRTC) reported Other Non-Current Liabilities of $1.2 million for Q4 2025, down 34.61% year-over-year from $1.9 million in Q4 2024, and up 42.84% on a QoQ basis from $852000.0 in Q2 2025.
PureTech Health (PRTC) has 6 years of Other Non-Current Liabilities data on file, last reported at $1.2 million in Q4 2025.
- Quarterly Other Non-Current Liabilities fell 34.61% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 million (down 34.61% YoY) and the FY2025 annual result came in at $1.2 million, down 34.61% from the prior year.
- Other Non-Current Liabilities climbed to $1.2 million in Q4 2025 per PRTC's latest filing, from $852000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $16.9 million in Q4 2021 and bottomed at $852000.0 in Q2 2025.
- The 5-year median for Other Non-Current Liabilities is $2.7 million (2023), against an average of $6.5 million.
- The widest annual swing landed in 2021, when Other Non-Current Liabilities advanced 14.19%; it then tumbled 75.64% in 2023.
- Tracing PRTC's Other Non-Current Liabilities over 5 years: stood at $16.9 million in 2021, then declined by 15.06% to $14.4 million in 2022, then plunged by 75.64% to $3.5 million in 2023, then sank by 46.84% to $1.9 million in 2024, then slumped by 34.61% to $1.2 million in 2025.
- Per Business Quant, the three latest PRTC Other Non-Current Liabilities figures stand at $1.2 million (Q4 2025), $852000.0 (Q2 2025), and $1.9 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.22 Mn |
| Jun 30, 2025 | 852,000.00 |
| Dec 31, 2024 | 1.86 Mn |
| Dec 31, 2023 | 3.50 Mn |
| Dec 31, 2022 | 14.37 Mn |
| Dec 31, 2021 | 16.92 Mn |
| Dec 31, 2020 | 14.82 Mn |